Intellia Therapeutics shares owned by Schroder Investment Management Group
Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Schroder Investment Management Group
from 13F filings
Historical chart of Schroder Investment Management Group investment in Intellia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Intellia Therapeutics held by Schroder Investment Management Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intellia Therapeutics by Schroder Investment Management Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $3.8M | 406k | 9.38 |
| 2025-03-31 | $194k | 24k | 8.07 |
| 2024-12-31 | $274k | 24k | 11.41 |
| 2024-09-30 | $1.8M | 86k | 21.00 |
| 2024-06-30 | $1.9M | 87k | 22.38 |
| 2024-03-31 | $2.4M | 87k | 27.51 |
| 2023-12-31 | $2.7M | 89k | 30.49 |
| 2023-09-30 | $4.1M | 130k | 31.62 |
| 2023-06-30 | $5.8M | 142k | 40.78 |
| 2023-03-31 | $6.1M | 164k | 37.27 |
| 2022-12-31 | $3.8M | 108k | 34.89 |
| 2022-09-30 | $4.7M | 84k | 55.96 |
| 2022-06-30 | $4.8M | 92k | 52.43 |
| 2022-03-31 | $6.5M | 90k | 72.18 |
More positions owned by Schroder Investment Management Group
View all positions for Schroder Investment Management Group